<DOC>
	<DOCNO>NCT02195453</DOCNO>
	<brief_summary>The purpose study observe quality life treatment side effect patient advance non small cell lung cancer ( NSCLC ) receive chemotherapy Yangzhengxiaoji capsule .</brief_summary>
	<brief_title>Chemotherapy Combined With Yangzhengxiaoji Capsule Patients With Advanced Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Inclusion criterion : 1 . Histology and/or cytology confirm stage Ⅳ NSCLC patient ; 2 . With least one measurable solid tumor ( RECIST standard version 1.1 ) : tumor &gt; =10 mm diameter CT MRI image , lymph node &gt; =15 mm diameter CT MRI image ; 3 . Eastern Cooperative Oncology Group ( ECOG ) score 01 , expectant survival &gt; 3 month ; 4 . Age : 1870 year ; 5 . Normal organ function : Bone marrow : neutrophil ( ANC ) count &gt; =1.5×10^9/L , Platelets count &gt; =100×10^9/L , hemoglobin &gt; =90g/L；Renal function , serum creatinine &lt; =1.5 mg/dl , and/or creatinine clearance &gt; =60 ml/min ; Liver function : total serum bilirubin level &lt; = 1.5 time upper limit normal ( ULN ) , serum aspartate aminotransferase ( AST ) serum alanine aminotransferase ( ALT ) &lt; =2.5 time ULN , abnormal liver function cause underlying malignancy , AST ALT &gt; =5 time ULN ; 6 . For patient brain metastasis , bone metastasis pleural effusion , systemic chemotherapy propose effective local treatment control symptom ; 7 . Informed consent . Exclusion criterion : 1 . Clinically significant hepatic dysfunction : AST ALT &gt; 2.5 time ULN , total serum bilirubin level &gt; 1.5 time ULN ; clinically significant renal insufficiency : serum creatinine &gt; 1.5 time ULN ; 2 . Severe heart disease : New York Heart Association class ⅢIV class heart failure , unstable angina , myocardial infarction , coronary revascularization six month randomization ; 3 . Spleen resection combine severe hematopoietic system diseases ; 4 . Uncontrolled diabetes , hypertension ( 180/120mmHg ) , infection severe gastrointestinal ulcer ; 5 . History present cancer , except non melanoma skin cancer , cervical cancer situ cure cancer least 5 year ; 6 . Mental illness , without legal capacity limit capacity ; 7 . Pregnancy , lactation patient pregnancy plan ; 8 . Participated clinical trail past 1 month participate trail ; 9 . Other unsuitable condition decide investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Non-small cell lung cancer</keyword>
	<keyword>FACT-L scale</keyword>
	<keyword>Yangzhengxiaoji</keyword>
</DOC>